targeting mitochondrial vulnerabilities in multiple myeloma
Published 1 year ago • 68 plays • Length 1:44Download video MP4
Download video MP3
Similar videos
-
0:36
the potential of immunotherapies in the myeloma treatment landscape
-
1:17
targeting mitochondrial metabolism to eradicate mrd in aml
-
2:44
dual-targeting bispecific antibody alnuctamab in r/r multiple myeloma
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
1:00:53
how fast can multiple myeloma progress and what biologically happens when it does?
-
2:17
mrd: a promising biomarker in multiple myeloma
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
2:33
the role of bispecific antibodies in the treatment of patients with multiple myeloma
-
2:44
novel bcma-targeting therapies to treat tce relapsed/refractory multiple myeloma
-
4:27
antibody-based targeting of bcma in multiple myeloma
-
2:43
targeting multiple myeloma antigens
-
2:01
ctcs as a biomarker of tumor burden in multiple myeloma
-
4:58
overview of the toxicities associated with bispecific agents in multiple myeloma
-
4:02
an overview of bispecifics in r/r myeloma and their integration into the treatment landscape
-
2:44
myeloma qol through induction and maintenance
-
1:53
the future of multiple myeloma treatment
-
2:39
advancements in bispecific and trispecific antibodies for the treatment of lymphoma
-
2:46
managing patients with high-risk myeloma
-
2:42
hdac8: a novel therapeutic target in multiple myeloma
-
1:01
car-t: myeloma toxicities
-
9:52
myeloma highlights from soho 2023: updates with the use of novel targeted immunotherapies